REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC is a federal contractor, registered under UEI N3F9MH7E6HD6 and CAGE code 544P9. It has been awarded $6,874,661,000 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing, Research and Development in Biotechnology, and Other NAICS codes (2 codes, <0.5% each). Top awarding agencies include Department Of Defense, Department Of Health And Human Services, and Other agencies (1 agencies, <0.5% each).
Contact Information
Registration and classification details
Registration
UEI Code
N3F9MH7E6HD6CAGE Code
544P9Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Regeneron Pharmaceuticals Inc. specializes in biotechnology research and development and the manufacturing of pharmaceutical preparations, with deep expertise in clinical-stage drug development, hematological therapeutics, and precision medicine platforms. The company’s technical capabilities includ...
Regeneron Pharmaceuticals Inc. specializes in biotechnology research and development and the manufacturing of pharmaceutical preparations, with deep expertise in clinical-stage drug development, hematological therapeutics, and precision medicine platforms. The company’s technical capabilities include advanced molecular biology, recombinant protein production, and GMP-compliant manufacturing of biologics and small-molecule therapeutics. Their work involves iterative optimization of therapeutic candidates, regulatory alignment for FDA submissions, and lifecycle management of approved pharmaceutical products, with demonstrated proficiency in modifying study protocols, extending clinical trial timelines, and managing fiscal and operational adjustments under federal research agreements. Regeneron maintains consistent engagement with the Department of Health and Human Services and the Department of Veterans Affairs, primarily supporting federally funded biomedical research initiatives and the procurement of specialized pharmaceuticals for veteran healthcare systems. Their relationship with HHS centers on long-term R&D partnerships involving joint oversight committees and protocol revisions for clinical trials, while VA engagements focus on reliable supply chain delivery of high-complexity drugs, including hematology-related therapeutics, under Federal Supply Schedule contracts. The contractor operates primarily under NAICS 541711 for biotech R&D and 325412 for pharmaceutical manufacturing, positioning itself at the intersection of innovation and scalable production in the biopharmaceutical sector. Their vertical specialization lies in developing and commercializing monoclonal antibodies and targeted therapies for chronic and rare diseases, leveraging proprietary platforms for antibody discovery and process scale-up. As a large, privately held entity headquartered in Tarrytown, New York, Regeneron Pharmaceuticals Inc. operates with a full-scale internal manufacturing and R&D infrastructure. While no government certifications are listed, their consistent performance on federally funded contracts demonstrates established compliance with federal quality, safety, and reporting standards for pharmaceutical development and supply.
Key Performance Metrics
Awards Count
17
All time
Active
2
Currently performing
Completed
15
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with REGENERON PHARMACEUTICALS INC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for REGENERON PHARMACEUTICALS INC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
